Maquinto, Clarkson B.
HRN: 18-00-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/13/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/13/2024
12/20/2024
IV
675 Mg
Q6hrs
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes